Advanced Philadelphia chromosome positive acute lymphoblastic leukemia patients relapsed after treatment with tyrosine-kinase inhibitors: successful response to clofarabine and cyclophosphamide.
Vitale
Antonella
A
Grammatico
Sara
S
Capria
Saveria
S
Fiocchi
Carina
C
Foà
Robin
R
Meloni
Giovanna
G
D000227:Adenine Nucleotides / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001087:Arabinonucleosides / Q000008:administration & dosage; D000077866:Clofarabine; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D012008:Recurrence
D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D047428:Protein Kinase Inhibitors; D000077866:Clofarabine; D003520:Cyclophosphamide